References
- Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Prac 2011; 6(1):18–31.
- Garland EL, Howard MO, Vaughn MG, Perron BE. Volatile solvent misuse in the United States. Subst Use Misuse 2011; 46(S1):8–20.
- Wu LT, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry 2004; 43(10):1206–1214.
- Wu LT, Ringwalt CL. Inhalant use and disorders among adults in the United States. Drug Alcl Depend 2006; 85(1):1–11.
- Balster RL. Neural basis of inhalant abuse. Drug Alc Depend 1998; 51(1–2):207–214.
- Johnston CH. The role of sensations and feelings under ether. J Ab Psych 1909; 4:17–31.
- Beauvais F, Oetting ER. Toward a clear definition of inhalant abuse. Int J Addict 1987; 22(8):779–784.
- Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychological impairment and MRI abnormalities associated with chronic solvent abuse. Clin Toxicology 2002; 40(1):21–34.
- Tenebein M, Pillay N. Sensory evoked potentials in inhalant (volatile solvent) abuse. J Paediatr Child Health 1993; 2(3): 206–208.
- Dell C, Gust SW, MacLean S, eds. Special issue: Volatile substance misuse: A global perspective. Subst Use Misuse 2011; 46(S1):1–147.
- Bowen SE. Two serious and challenging medical complications associated with volatile substance misuse: Sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 2011; 46(S1):68–72.
- Dingwall KM, Cairney S. Recovery from central nervous system damage following volatile substance misuse. Subst Use Misuse 2011; 46(S1):73–83.
- Garland EL, Howard MO. Phenomenology of adolescent inhalant intoxication. Exp Clin Psychopharmacol 2010; 18(6):498–509.
- Garland EL, Howard MO. Adverse consequences of acute inhalant intoxication. Exp Clin Psychopharmacol 2011; 19(2):134–144.
- Howard MO, Garland EL. Adolescent volatile substance misuse: Atypical agents, perceived intoxication, and patterns of use. Submitted for publication.
- Perron BE, Howard MO, Maitra S, Vaughn MG. Prevalence, timing, and predictors of transitions from inhalant use to inhalant use disorders. Drug Alc Depend 2009; 100(3):277–284.
- Perron BE, Howard MO, Vaughn MG, Jarman CN. Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder. Med Hypotheses 2009; 73(6):935–937.
- Perron BE, Howard MO. Adolescent inhalant use, abuse, and dependence. Addiction 2009; 104(7):1185–1192.
- Perron BE, Vaughn MG, Howard MO. Reasons for using inhalants: Evidence for discrete classes in a sample of incarcerated adolescents. J Subst Abuse Treat 2008; 34(4):450–455.
- Howard MO, Balster R, Cottler LB, Wu LT, Vaughn MG. Inhalant use among incarcerated adolescents: Prevalence, characteristics, and predictors of use. Drug Alc Depend 2008; 93(3):197–209.
- Wu LT, Howard MO. Psychiatric disorders among inhalant users: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alc Depend 2007; 88(2–3):146–155.
- Perron BE, Mowbray O, Bier S, Vaughn MG, Krentzman A, Howard MO. Service use and treatment barriers among inhalant users. J Psychoactive Drugs 2011; 43(1):69–75.